pregnancy complicates heart disease/chronic hypertension/immune disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Females of childbearing age from 20 years old (including 20 years old) to 45 years old (including 45 years old); 2. Pregnant women who agreed to participate in this study and signed an informed consent form; 3. This pregnancy is a singleton pregnancy; 4. Establish the "Maternal Health Manual" no later than the 14th week of pregnancy, and have complete and true health records; 5. Have the conditions to be followed up to the end of pregnancy.
Exclusion criteria
Exclusion criteria: 1. Those who have difficulty in follow-up during pregnancy; 2. Other situations where the investigator believes it is not suitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall incidence of adverse pregnancy outcomes; | — |
Secondary
| Measure | Time frame |
|---|---|
| the incidence of fetal loss;the incidence of SGA;the incidence of preterm birth;the incidence of postpartum hemorrhage;the incidence of placental abruption;the incidence of preeclampsia;the incidence of eclampsia;the incidence of amniotic fluid embolism;the incidence of DIC;the incidence of Cardiovascular accident;the incidence of Life-threatening condition of primary disease;the incidence of Damage to vital organs; | — |
Countries
China
Contacts
Renji Hospital, Shanghai Jiao Tong University School of Medicine